You are here

A piece of news

usMIMA, Subtilis Biomaterials and Tractivus selected best bio companies of the year

The BioEmprenedorXXI awards give out a total of €21,000 in prize money

AddToAny buttons: 

usMIMA –an start-up that has come out of the d·HEALTH Barcelona postgraduate program promoted by Biocat to accelerate innovation in medical technology for healthcare- has won this year’s BioEmprenedorXXI award, which recognizes the business projects in the life sciences sector with the greatest potential for growth. Subtilis and Tractivus were first and second runners-up, respectively.

The finalists also included the Kocoon project, also from the d·HEALTH Barcelona program, which designed a sophisticated device using new materials to protect premature babies from excess noise.

la Caixa”, the Barcelona City Council –through Barcelona Activa- and Biocat promote this award valued at a total of €21,000, plus a package of growth-acceleration activities and training, internationalization and incubation actions, for the winning company and two runners-up.

Furthermore, the winning company will receive a free stay at the Barcelona Activa Glòries Business Incubator and fiscal and financial guidance from the Vilar Riba group, as well as, just like the first and second runners-up, the status of associated company at the Barcelona Science Park.

The independent panel of judges charged with assessing the projects was made up of more than twenty representatives of companies and organizations from the life sciences sector.

The award was presented at an event on new trends in technology transfer, the regional closing event of the ETTBio project, of which Biocat is a partner.

BioEntrepreneurs receive €21,000

usMIMA, a start-up that has come out of the d·HEALTH Barcelona program, won €12,000. This company has developed a wearable medical device controlled by central software that simulates therapeutic massages as a non-invasive, non-pharmacological treatment for chronic constipation without side effects. The team is made up of four entrepreneurs with multidisciplinary profiles who detected the business opportunity while on a clinical immersion at the Institut Guttmann.

The first runner-up, Subtilis Biomaterials, received €6,000. This spin-off of the Polytechnic University of Catalonia designs, manufactures and markets orthopedic and dental bone-regeneration solutions.

Tractivus, which received €3,000, is the result of a collaboration between GEMAT (Materials Engineering Group), Institut Químic de Sarrià (IQS) and Bellvitge Biomedical Research Institute (IDIBELL). They have designed two types of technology with antibacterial properties to administer the proper dose of drugs over time, designed as a solution to stent-related complications.

Public-private partnership to foster innovative spirit and innovation

BioEmprenedorXXI is a program providing training, guidance and support for the creation and growth of technology-based companies in the life sciences arena. This year, a total of 13 entrepreneurs have participated, 7 of which have already set up their company and 3 that are in the process of doing so. "In total, over the seven editions held so far, we have guided 108 business projects, 61 of which have become companies, raised more than €41.5 millions in funding and created more than 250 new jobs,” explained Biocat CEO Montserrat Vendrell at the awards ceremony.

The aim is to create a solid foundation of new companies with potential for growth and to foster interaction among all the stakeholders in the sector, as well as transferring research developed at universities and research centers to market.


Press release:

Related news:

An initiative off:    





 With the support of:

usMIMA was chosen the winner of the 2014 BioEmprenedorXXI award.

Related content: